Episode
Why Private Equity Is Buying Up Hearing Aid Clinics
- Published
- Jun 22, 2026
- Duration seconds
- 581
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/episodes/why-private-equity-is-buying-up-hearing-aid-clinics/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/why-private-equity-is-buying-up-hearing-aid-clinics.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of The Buyout Show, Lucas and Luna examine the quiet roll-up of the hearing aid industry by private equity. With an aging population and margin-rich business models, firms like Sonova and Demant have seen their clinic networks snapped up. The hosts break down why audiology practices are a PE dream: sticky patient relationships, high margin recurring revenue from batteries and fittings, and a fragmented market ripe for consolidation. They look at the economics of a typical practice, the regulatory changes from the 2017 OTC Hearing Aid Act that shifted the landscape, and whether this consolidation will ultimately help or hurt patients. A case study in how demographics and dealmaking intersect. #PrivateEquity #HearingAid #Audiology #RollUp #HealthcareM&A #Demographics #Sonova #Demant #OtcHearingAid #FragmentedMarket #Consolidation #Business #Finance #Investing #Healthcare #FexingoBusiness #BusinessPodcast #BuyoutShow Keep every episode free: buymeacoffee.com/fexingo